Stan Bernard, MD

"Payers have evolved to become powerful global contenders with pharma for increasingly limited funding of drug budgets."

Game-changers can create competitive advantages for pharmaceutical companies and products.

Increasingly, pharma companies are expanding from brand vs. brand to battle at the franchise, portfolio, and corporate levels.

Launching a product? Your competition likely plans to interfere. Here's how to counter a counter-launch.

Every industry has a life cycle, and pharma's has just entered its competitive stage. Here's how to prepare.

It's time for the big project. Top management in a leading pharma company wants executive A, a rising star in the marketing department, to evaluate a new technology's impact on the industry-and on his company. The technology has the potential to dramatically affect not only pharmaceutical discovery and development but also marketing and sales. But there are many factors to analyze, and no one in his company has the expertise to do it.